Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.

Andrade MO, Cunha VSD, Oliveira DC, Moraes OL, Lofrano-Porto A.

Arch Endocrinol Metab. 2018 Mar-Apr;62(2):264-269. doi: 10.20945/2359-3997000000033. Review.

2.

Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.

van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.

J Nucl Med. 2015 Jun;56(6):839-46. doi: 10.2967/jnumed.115.154815. Epub 2015 Apr 16.

3.

Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.

Tiwari A, Shah N, Sarathi V, Malhotra G, Bakshi G, Prakash G, Khadilkar K, Pandit R, Lila A, Bandgar T.

J Med Imaging Radiat Oncol. 2017 Dec;61(6):745-752. doi: 10.1111/1754-9485.12620. Epub 2017 Jun 5.

PMID:
28585398
4.

Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.

Korpershoek E, Petri BJ, van Nederveen FH, Dinjens WN, Verhofstad AA, de Herder WW, Schmid S, Perren A, Komminoth P, de Krijger RR.

Endocr Relat Cancer. 2007 Jun;14(2):453-62.

PMID:
17639058
5.

Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.

Choi YM, Sung TY, Kim WG, Lee JJ, Ryu JS, Kim TY, Kim WB, Hong SJ, Song DE, Shong YK.

J Surg Oncol. 2015 Dec;112(8):815-21. doi: 10.1002/jso.24063. Epub 2015 Oct 14.

PMID:
26464058
6.

Long-term prognosis of patients with pediatric pheochromocytoma.

Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall'igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Rácz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP.

Endocr Relat Cancer. 2013 Dec 16;21(1):17-25. doi: 10.1530/ERC-13-0415. Print 2014 Feb.

PMID:
24169644
7.

Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.

Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J Jr, Pacak K.

Endocr Relat Cancer. 2008 Mar;15(1):311-23. doi: 10.1677/ERC-07-0217.

PMID:
18310297
8.

Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.

Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF.

J Clin Endocrinol Metab. 2007 Oct;92(10):3822-8. Epub 2007 Jul 24.

PMID:
17652212
9.

[Hereditary pheochromocytoma-associated syndromes. Part 1].

Yukina MY, Troshina EA, Beltsevich DG.

Ter Arkh. 2015;87(9):102-105. doi: 10.17116/terarkh2015879102-105. Review. Russian.

PMID:
26591561
10.

SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.

Hadoux J, Favier J, Scoazec JY, Leboulleux S, Al Ghuzlan A, Caramella C, Déandreis D, Borget I, Loriot C, Chougnet C, Letouzé E, Young J, Amar L, Bertherat J, Libé R, Dumont F, Deschamps F, Schlumberger M, Gimenez-Roqueplo AP, Baudin E.

Int J Cancer. 2014 Dec 1;135(11):2711-20. doi: 10.1002/ijc.28913. Epub 2014 May 5.

11.

Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.

Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, Khare S, Nair S, Raghavan V, Dalvi A, Hira P, Fernandes G, Sathe P, Rojekar A, Malhotra G, Bakshi G, Prakash G, Bhansali A, Walia R, Kamalanathan S, Sahoo J, Desai A, Bhagwat N, Mappa P, Rajput R, Chandrashekhar SR, Shivane V, Menon P, Lila A, Bandgar T, Shah N.

Eur J Endocrinol. 2016 Oct;175(4):311-23. doi: 10.1530/EJE-16-0126. Erratum in: Eur J Endocrinol. 2016 Dec;175(6):X3.

PMID:
27539324
12.

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.

van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, van de Meiracker AH, Boomsma F, Stijnen T, Krenning EP, Bosman FT, Kwekkeboom DJ.

J Clin Endocrinol Metab. 2001 Feb;86(2):685-93.

PMID:
11158032
13.

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.

Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K.

J Clin Oncol. 2007 Jun 1;25(16):2262-9.

PMID:
17538171
14.

Familial nonsyndromic pheochromocytoma.

Opocher G, Schiavi F, Iacobone M, Toniato A, Sattarova S, Erlic Z, Martella M, Mian C, Merante Boschin I, Zambonin L, De Lazzari P, Murgia A, Pelizzo MR, Favia G, Mantero F.

Ann N Y Acad Sci. 2006 Aug;1073:149-55.

PMID:
17102081
15.

Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.

Khadilkar K, Sarathi V, Kasaliwal R, Pandit R, Goroshi M, Shivane V, Lila A, Bandgar T, Shah NS.

J Pediatr Endocrinol Metab. 2017 May 1;30(5):575-581. doi: 10.1515/jpem-2016-0375.

PMID:
28432847
16.

Role of miR-101 in pheochromocytoma patients with SDHD mutation.

Zong L, Meng L, Shi R.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1545-54. eCollection 2015.

17.

Mutations seen among patients with pheochromocytoma and paraganglioma at a referral center from India.

Pai R, Ebenazer A, Paul MJ, Thomas N, Nair A, Seshadri MS, Oommen R, Shanthly N, Devasia A, Rebekah G, Jeyaseelan L, Rajaratnam S.

Horm Metab Res. 2015 Feb;47(2):133-7. doi: 10.1055/s-0034-1376989. Epub 2014 Jun 30.

PMID:
24977658
18.

A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literature.

Kurisaki-Arakawa A, Saito T, Takahashi M, Mitani K, Yao T.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4438-47. eCollection 2014. Review.

19.

Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.

Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL.

Ann Surg Oncol. 2013 May;20(5):1444-50. doi: 10.1245/s10434-013-2942-5. Epub 2013 Mar 20.

20.

Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.

Meyer-Rochow GY, Smith JM, Richardson AL, Marsh DJ, Sidhu SB, Robinson BG, Benn DE.

J Surg Res. 2009 Nov;157(1):55-62. doi: 10.1016/j.jss.2008.07.043. Epub 2008 Sep 4.

PMID:
19215943

Supplemental Content

Support Center